Physician profile
Ronald Watts
NPI 1942301759
$45,577.49
in general payments reported to CMS, 2019-2025
52 companies · $5,321 in 2025
The $5,321 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $7,514 · 2021: $4,695 · 2022: $4,332 · 2023: $4,461 · 2024: $4,589 · 2025: $5,321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Education: $169 · Gift: $59.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,142.61 |
| Education | $169.30 |
| Gift | $59.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $12,852.66 | 2019-2023 | |
| Xeris Pharmaceuticals, INC. | $3,905.68 | 2020-2025 | Recorlev, Gvoke Hypopen |
| Amgen INC. | $2,939.79 | 2019-2025 | Evenity, Repatha, Tepezza |
| Novo Nordisk INC | $2,719.94 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $2,355.87 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $2,196.03 | 2019-2025 | Synthroid |
| Mannkind Corporation | $2,030.81 | 2019-2025 | Afrezza |
| Corcept Therapeutics | $1,978.77 | 2020-2025 | Korlym |
| Insulet Corporation | $1,929.08 | 2019-2025 | Omnipod, Omnipod |
| Bayer Healthcare Pharmaceuticals INC. | $1,701.00 | 2022-2025 | |
| Medtronic, INC. | $1,584.40 | 2021-2025 | Minimed 780g, Minimed 770g |
| Sanofi-Aventis U.S. LLC | $1,391.13 | 2019-2025 | |
| Dexcom, INC. | $637.53 | 2020-2025 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Esperion Therapeutics, INC. | $633.57 | 2020-2025 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $622.78 | 2019-2025 | Jardiance |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $596.92 | 2019-2020 | |
| Radius Health, INC. | $584.63 | 2019-2025 | Tymlos |
| Companion Medical, INC. | $549.16 | 2019-2020 | |
| Ibsa Pharma INC. | $466.11 | 2019-2025 | Tirosint, Licart, Tirosint |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $444.31 | 2019-2023 | Cycloset |
| Novartis Pharmaceuticals Corporation | $383.74 | 2022-2025 | |
| Ascendis Pharma Endocrinology INC | $342.58 | 2023-2025 | Yorvipath |
| Janssen Pharmaceuticals, INC | $279.70 | 2019-2020 | |
| Recordati_rare_diseases_inc. | $237.97 | 2021-2025 | Isturisa, Signifor Lar |
| Alexion Pharmaceuticals, INC. | $228.40 | 2022-2025 | Strensiq |
| Amneal Pharmaceuticals LLC | $213.25 | 2019-2024 | Unithroid |
| Sequel Med Tech, LLC | $196.28 | 2025 | Twiist |
| Abbott Laboratories | $165.11 | 2020-2025 | Freestyle Libre 3 |
| Cequr Corporation | $155.72 | 2023-2025 | Cequr Simplicity |
| Regeneron Healthcare Solutions, INC. | $133.61 | 2019-2023 | Evkeeza |
| Tandem Diabetes Care, INC. | $129.00 | 2019-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Antares Pharma, INC. | $118.33 | 2022-2025 | Xyosted |
| Senseonics, Incorporated | $105.00 | 2019-2020 | |
| Lifescan, INC. | $102.59 | 2021-2023 | |
| Astellas Pharma US INC | $85.43 | 2023-2024 | Veozah |
| Merck Sharp & Dohme LLC | $82.61 | 2019-2023 | Verquvo, Steglatro |
| Amarin Pharma, INC. | $78.51 | 2019 | |
| Shire North American Group INC | $61.57 | 2019 | |
| Currax Pharmaceuticals LLC | $54.16 | 2019-2023 | Nexletol |
| Ionis Pharmaceuticals, INC. | $50.11 | 2025 | Tryngolza |
| Madrigal Pharmaceuticals | $45.71 | 2025 | Rezdiffra |
| Pfizer INC. | $43.00 | 2019-2021 | |
| Amphastar Pharmaceuticals, INC. | $36.60 | 2024-2025 | |
| Ultragenyx Pharmaceutical INC. | $21.49 | 2022 | |
| Kyowa Kirin, INC. | $20.35 | 2023 | Crysvita |
| Amryt Pharma Holdings Ltd | $20.27 | 2022 | |
| Eisai INC. | $20.08 | 2023 | |
| Horizon Therapeutics Plc | $18.33 | 2022 | |
| Nevro Corp. | $14.44 | 2022 | |
| Cardiovascular Systems INC. | $13.38 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Watts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.